|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 25/28 | |
| A61K 31/4985 | |||
| A61K 9/50 |
| (11) | Number of the document | 2968320 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14765123.6 |
| Date of filing the European patent application | 2014-03-15 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/029914 |
| Date | 2014-03-15 |
| (87) | Number | WO 2014/145192 |
| Date | 2014-09-18 |
| (30) | Number | Date | Country code |
| 201361799405 P | 2013-03-15 | US |
| (72) |
LI, Peng, US
ZHANG, Qiang, US
DAVIS, Robert, US
WENNOGLE, Lawrence, P., US
|
| (73) |
Intra-Cellular Therapies, Inc.,
430 East 29th Street, Suite 900, New York, NY 10016,
US
|
| (54) | ORGANIC COMPOUNDS |
| ORGANIC COMPOUNDS |